Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousTissue DonorsWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalBusulfanBone Marrow PurgingHematopoietic Stem CellsHistocompatibility TestingHistocompatibilityCyclophosphamideTransplantation, IsogeneicKidney TransplantationBone Marrow DiseasesHematopoiesisRecurrenceMice, Inbred C57BLCombined Modality TherapyT-LymphocytesTime FactorsRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteTreatment OutcomeImmunosuppressive AgentsBone Marrow ExaminationGraft RejectionHematologic NeoplasmsRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation ImmunologyHepatic Veno-Occlusive DiseaseBone RemodelingLeukemia, MyeloidImmunosuppressionLymphocyte DepletionGraft vs Host ReactionBone Marrow NeoplasmsLeukocyte TransfusionAcute DiseaseStem Cell TransplantationLiving DonorsLymphoma, Non-HodgkinHeart TransplantationLeukocytes, MononuclearColony-Forming Units AssayFlow CytometryHLA AntigensChimeraLeukocyte CountCells, CulturedSevere Combined ImmunodeficiencyRetrospective StudiesSurvival AnalysisMyelodysplastic SyndromesLung TransplantationBlood DonorsLymphocytesGranulocyte Colony-Stimulating FactorCyclosporinePeripheral Blood Stem Cell TransplantationCell DifferentiationHematologic DiseasesLymphocyte TransfusionBlood CellsActuarial AnalysisAntineoplastic Combined Chemotherapy ProtocolsBone DensitySpleenNuclear FamilyAntigens, CD34Organ TransplantationFollow-Up StudiesCarmustineImmunophenotypingPancytopeniaCytomegalovirus InfectionsGraft vs Tumor EffectSurvival RateMice, Inbred BALB CCytarabineGraft vs Leukemia EffectMelphalanLymphocyte ActivationMultiple MyelomaCell SeparationLymphomaAntigens, CDDisease-Free Survival